{"SPADE_UN_17125": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17125", "Peptide Name": 44, "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "KRPTMRFRYTWNPMK", "Sequence Length": 15, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Chymotrypsin hydrolysis", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C91H142N28O20S2", "Mass": 2012.41, "PI": 11.73, "Net Charge": 5, "Hydrophobicity": -1.67, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Comments": "Resisting chymotrypsin hydrolysis", "Literature": [{"Title": "Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.", "Pubmed ID": "22805558", "Reference": "Nat Commun. 2012 Jul 17;3958.", "Author": "Kondo E, Saito K, Tashiro Y, Kamide K, Uno S, Furuya T, Mashita M, Nakajima K, Tsumuraya T, Kobayashi N, Nishibori M, Tanimoto M, Matsushita M.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22805558"}], "Frequent Amino Acids": "RKM", "Absent Amino Acids": "ACDEGHILOQSUV", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 9, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_16073", "Similarity": 0.5, "Sequence": "MHKRPTTPSRKM"}, {"SPADE_ID": "SPADE_UN_22916", "Similarity": 0.5, "Sequence": "RFRRFRRFRRFR"}]}}}